La importancia del estudio familiar y genético: la mutación p. L3778F en el receptor de la rianodina probablemente no cause un fenotipo tan grave

Val Groba-Marco, María del; Benito-Bartolomé, Fernando; García-Aguado, Marcos; García-Hernández, Irene; Gimeno-Blanes, Juan Ramón; Barriales-Villa, Roberto.
Rev. esp. cardiol. (Ed. impr.) ; 69(7): 702-704, jul. 2016. ilus, graf, tab
Artículo en Español | IBECS (España) | ID: ibc-154090

Documentos relacionados

  1. RyR2 C-terminal truncating variants identified in patients with arrhythmic phenotypes exert a dominant negative effect through formation of wildtype-truncation heteromers.
  2. The V2475F CPVT1 mutation yields distinct RyR2 channel populations that differ in their responses to cytosolic Ca<sup>2+</sup> and Mg<sup>2</sup>.
  3. Molecular and tissue mechanisms of catecholaminergic polymorphic ventricular tachycardia.
  4. RYR2-ryanodinopathies: from calcium overload to calcium deficiency.
  5. [Hypertrophic cardiomyopathy complicating with ventricular tachycardia induced by MYBPC3 and RYR2 double gene mutations: a case report].
  6. Rare RYR2 p.Thr85Ile variant is associated with catecholaminergic polymorphic ventricular tachycardia.
  7. Current management of inherited arrhythmia syndromes associated with the cardiac ryanodine receptor.
  8. 50 Years of Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) - Time to Explore the Dark Side of the Moon.
  9. A Clinical Case of Catecholaminergic Polymorphic Ventricular Tachycardia: The Clinical Suspicious and the Need of Genetics.
  10. A novel RyR2 mutation associated with co-morbid catecholaminergic polymorphic ventricular tachycardia (CPVT) and benign epilepsy with centrotemporal spikes (BECTS).